News iRhythm digital heart monitoring service backed by NICE A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies.
Partner Content Partner Content Patient Monitoring Devices Market will grow at 5% CAGR betwe... Patient Monitoring Devices Market worth $27bn by 2025
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.